AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026)
AbCellera Biologics (ABCL) posted Enterprise Value of $1.87 billion for Q2 2026, up 304.4% from $461.37 million a year earlier and up 235.5% from the prior quarter.
AbCellera Biologics (ABCL) Enterprise Value (2020 - 2026) Analysis & Trends
For FY2025, AbCellera Biologics' Enterprise Value came in at $494.23 million, up 98.8% from FY2024.
- Annual Enterprise Value shows a five-year compound annual growth rate of -38.9% (FY2020 to FY2025).
- In prior years, AbCellera Biologics' Enterprise Value was $248.57 million in FY2024 (-72.9%), $915.99 million in FY2023 (-55.0%), $2.04 billion in FY2022 (-38.8%) and $3.33 billion in FY2021 (-42.7%).
- The Q2 2026 figure stands as the highest quarterly Enterprise Value since Q4 2022.
- On a year-over-year basis, Enterprise Value has increased in each of the last five quarters, with growth averaging 252.4% over the last eight quarters.
- The strongest year-over-year quarter for Enterprise Value in the past five years was Q1 2026, with growth of 924.5%; the weakest was Q1 2025, with a decline of 91.2%.
- According to Business Quant data, Enterprise Value for the three prior quarters was $556.04 million (Q1 2026), $494.23 million (Q4 2025) and $1.01 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | AbCellera Biologics | 3.89 Bn | 3.89 Bn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.87 Bn |
| Mar 31, 2026 | 556.04 Mn |
| Dec 31, 2025 | 494.23 Mn |
| Sep 30, 2025 | 1.01 Bn |
| Jun 30, 2025 | 461.37 Mn |
| Mar 31, 2025 | 54.27 Mn |
| Dec 31, 2024 | 248.57 Mn |
| Sep 30, 2024 | 113.01 Mn |
| Jun 30, 2024 | 190.49 Mn |
| Mar 31, 2024 | 619.41 Mn |
| Dec 31, 2023 | 915.99 Mn |
| Sep 30, 2023 | 533.68 Mn |
| Jun 30, 2023 | 1.06 Bn |
| Mar 31, 2023 | 1.37 Bn |
| Dec 31, 2022 | 2.04 Bn |
| Sep 30, 2022 | 1.96 Bn |
| Jun 30, 2022 | 2.01 Bn |
| Mar 31, 2022 | 1.99 Bn |
| Dec 31, 2021 | 3.33 Bn |
| Sep 30, 2021 | 5.12 Bn |
AbCellera Biologics Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABCL&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ABCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();